Skip to main content
. 2021 Sep 2;10(4):2157–2175. doi: 10.1007/s40121-021-00533-4

Fig. 1.

Fig. 1

Vaccine strategies tested against Klebsiella pneumoniae: live attenuated vaccines based on genetically modified bacteria; inactivated whole cell vaccines; outer membrane vesicles containing numerous virulence factors; polysaccharide and lipopolysaccharide (LPS)-based vaccines; protein-based vaccine (recombinant or purified from bacterial extracts); conjugate vaccines including PS–protein or LPS–protein fusions; ribosomal vaccines